News

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...
Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.
The International Air Transport Association said on Sunday it expects the amount of sustainable aviation fuel produced to ...
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...
The firm saw an improvement in progression-free survival for patients on the ivonescimab regimen and a trend toward improved overall survival.
Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...
A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...
Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path to tackling pancreatic cancer.
Standard medical practice is to not test men who have a life expectancy of less than 10 years for prostate cancer.
A drug, Keytruda, one of the world's most effective cancer medications, promises to transform treatment by delivering ...
“Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary ...
Former President Joe Biden was diagnosed with an aggressive form of prostate cancer, his office announced on Sunday. The ...